• Hesperadin: Aurora B Kinase Inhibitor Workflow

  2026-09-12

  Hesperadin provides an acute, tunable way to interrogate Aurora B-dependent mitosis, from histone H3 Ser-10 phosphorylation to chromosome segregation and cytokinesis. This workflow combines quantitative dosing, checkpoint-focused controls, and troubleshooting guidance for cell cycle research and cancer research.

• Camostat Mesilate: Protease & Fibrosis Research

  2026-09-11

  Camostat Mesilate is a trypsin-like protease inhibitor used to study ENaC function, plasmin-dependent TGF-β signaling, and hepatic fibrosis. Its reported ENaC IC50 is 50 nM, while its fibrosis evidence remains preclinical and should not be conflated with structure-guided antiviral PPI inhibitors.

• Direct Mouse Genotyping Kit Plus Workflow

  2026-09-11

  Build a rapid, purification-free mouse genotyping workflow for transgene confirmation, knockout screening, and colony management. The Direct Mouse Genotyping Kit Plus combines direct tissue lysate preparation with a PCR master mix with dye reagents, helping researchers connect genotype decisions to complex experimental phenotypes.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-09-10

  The reference study identifies circulating moesin as a candidate marker of endothelial injury and sepsis severity, linking clinical measurements with mouse and endothelial-cell experiments. Its results connect moesin to Rock1/myosin light chain and NF-κB signaling, while also defining practical limits for translating the findings into mechanistic or therapeutic studies.

• Idoxuridine: From Viral DNA Mechanism to Translation

  2026-09-10

  Idoxuridine, also known as 5-iodo-2'-deoxyuridine, is more than a historical antiviral scaffold: it is a practical probe for connecting viral DNA synthesis, replication disruption, and translational assay design. This article outlines how to build stronger evidence around the compound while using human-tissue pharmacology as a model for rigorous target engagement.

• 5-(N,N-dimethyl)-Amiloride: NHE Workflow Guide

  2026-09-09

  Build sharper intracellular pH, endothelial-barrier, and cardiac ion-transport assays with a concentration-aware NHE workflow. This guide distinguishes evidence from practical recommendations and shows how to interpret DMA alongside moesin, permeability, sodium, and contractility readouts.

• IPR-803: A Practical Urokinase Receptor Inhibitor

  2026-09-09

  IPR-803 is a competitive uPAR–uPA interaction blocker for dissecting tumor invasion, metastasis, angiogenesis, and stromal barriers. Its value is strongest in mechanism-led workflows that pair biochemical target engagement with invasion, signaling, pharmacokinetic, or nanomedicine readouts.

• 740 Y-P for Reproducible PI3K/AKT Assays

  2026-09-08

  This scenario-based guide explains how 740 Y-P (SKU B5246) can support controlled PI3K/AKT pathway activation in cell viability, neuronal survival, cancer, and vesicular trafficking experiments. It covers assay design, stock preparation, interpretation, and practical vendor-selection criteria using product specifications and published pathway evidence.

• Patient-Derived Spheroids for Prostate Cancer Research

  2026-09-08

  The reference study established viable three-dimensional spheroid cultures from organ-confined prostate cancer specimens obtained during radical prostatectomy. These cultures preserved clinically relevant epithelial and androgen receptor markers, supported cryopreservation and drug testing, and revealed stronger viability loss with bicalutamide and enzalutamide than with docetaxel or abiraterone under the reported conditions.

• 7-Ethyl-10-hydroxycamptothecin: Assay Logic

  2026-09-07

  7-Ethyl-10-hydroxycamptothecin (SN-38) is more than a DNA topoisomerase I inhibitor. This article presents an evidence-based assay framework for separating topoisomerase-mediated DNA damage, FUBP1/FUSE disruption, cell-cycle arrest, and apoptosis in advanced colon cancer research.

• URB597 (KDS-4103) for FAAH Research

  2026-09-07

  URB597 (KDS-4103) provides a selective way to raise anandamide and test FAAH-dependent endocannabinoid signaling without directly activating cannabinoid receptors. This workflow-focused guide connects brain-membrane assays, intact-neuron experiments, and pain-related behavioral models with practical controls and troubleshooting strategies.

• Crystal Violet Staining Solution: Readout Logic

  2026-09-05

  Crystal Violet Staining Solution is more than a nuclear staining dye: its signal reflects how cells or biofilms remain attached to a surface. This guide connects assay chemistry, orthogonal validation, and practical interpretation for proliferation, migration, invasion, colony formation, and biofilm studies.

• NF 340: A Rigorous P2Y11 Signaling Study Guide

  2026-09-04

  NF 340 is a selective P2Y11 antagonist for dissecting purinergic GPCR signaling in cancer, immunology research, and inflammation studies. This evidence-aware guide explains what the QPRT breast cancer study establishes, how to design stronger assays, and where receptor-level conclusions remain limited.

• Tyrothricin Workflows for Membrane Research

  2026-09-04

  Tyrothricin is a practical peptide antibiotic mixture for connecting growth inhibition with direct membrane-injury measurements. This guide presents fresh-solution handling, quantitative bacterial and fungal assay workflows, cross-domain interpretation, and troubleshooting strategies for reproducible antimicrobial research.

• TPPU: A Soluble Epoxide Hydrolase Inhibitor

  2026-09-03

  TPPU is a nanomolar soluble epoxide hydrolase inhibitor for dissecting fatty acid epoxide signaling in inflammatory pain, osteoclast, and liver–bone experiments. Its high potency, human and mouse sEH activity, and compatibility with pharmacological and lipidomic workflows make it useful for separating target engagement from downstream Nrf2 and cytokine effects.

8553 records 1/571 page Next 12345 下5页 Last page